Product Description
for the Treatment of Mild Plaque Type Psoriasis Vulgaris. The PSO-CT02 device is a non CE marked investigational medical device that is worn on the affected skin area where it irradiates the Psoriasis plaque for 30 minutes with blue light. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02004847)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Philips Electronics Nederland BV
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| PsoriasisCT02 | N/A |
Completed |
Psoriasis |
2014-05-01 |
|
| EczemaCT01 | N/A |
Completed |
Dermatitis, Atopic |
2014-03-01 |